# Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

> **NCT04842422** · PHASE4 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 48 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** Imiquimod 3.75% Cream

## Key facts

- **NCT ID:** NCT04842422
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-16
- **Primary completion:** 2021-08-23
- **Final completion:** 2021-08-23
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04842422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04842422, "Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04842422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*